Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-11-2014 | Imaging in Cardiology

Acute coronary syndrome due to dilated coronaropathy in a young patient with gouty arthritis

Auteurs: U. Canpolat, L. Şahiner, K. Aytemir

Gepubliceerd in: Netherlands Heart Journal | Uitgave 11/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Extract

A 39-year-old male patient with no previously known cardiovascular risk factors was admitted with angina pectoris. His medical history was unremarkable except for gouty arthritis for 3 years. He did not smoke and there was no history of alcohol use. His medications included colchicine and allopurinol. Physical examination was unremarkable. Electrocardiography revealed sinus rhythm and 1–1.5 mm ST-segment depression in the inferior leads. The biochemistry panel was normal (LDL cholesterol: 88 mg/dl). Serum uric acid was 9.5 mg/dl (N: 2.1 – 7.6 mg/dl). Cardiac biomarkers were increased during follow-up. So, coronary angiography was attempted and showed diffuse ectatic coronary arteries with no significant stenosis (Fig. 1) and a prominent slow flow in the right coronary artery (RCA). The diameter of the RCA was 15 mm (Fig. 1a), the left anterior descending artery was 10 mm and the intermediate artery was 8 mm (Fig. 1b). The hospital course was uneventful and he was discharged on warfarin, aspirin, clopidogrel, beta-blocker and statin medications. He was asymptomatic at the one- and six-month follow-up visits and also treadmill exercise testing was normal at the six-month visit.
Literatuur
1.
go back to reference Kato M, Hisatome I, Tomikura Y, et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol. 2005;96(11):1576–8.PubMedCrossRef Kato M, Hisatome I, Tomikura Y, et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol. 2005;96(11):1576–8.PubMedCrossRef
2.
go back to reference Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–62.PubMedCrossRef Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–62.PubMedCrossRef
3.
go back to reference Jin M, Yang F, Yang I, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–69.CrossRef Jin M, Yang F, Yang I, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–69.CrossRef
4.
go back to reference Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25(1):39–42.PubMedCrossRef Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25(1):39–42.PubMedCrossRef
5.
go back to reference Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183–90.PubMedCrossRef Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183–90.PubMedCrossRef
6.
go back to reference Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170–80. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170–80.
7.
go back to reference Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894–900.PubMedCrossRef Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894–900.PubMedCrossRef
8.
go back to reference Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688–96.PubMedCrossRef Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688–96.PubMedCrossRef
Metagegevens
Titel
Acute coronary syndrome due to dilated coronaropathy in a young patient with gouty arthritis
Auteurs
U. Canpolat
L. Şahiner
K. Aytemir
Publicatiedatum
01-11-2014
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 11/2014
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0340-4